Cargando…

Neuraminidase Antibodies and H5N1: Geographic-Dependent Influenza Epidemiology Could Determine Cross-Protection against Emerging Strains

Detalles Bibliográficos
Autores principales:	Bermejo-Martin, Jesus F, Kelvin, David J, Guan, Yi, Chen, Honglin, Perez-Breña, Pilar, Casas, Inmaculada, Arranz, Eduardo, de Lejarazu, Raul O
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896207/ https://www.ncbi.nlm.nih.gov/pubmed/17593897 http://dx.doi.org/10.1371/journal.pmed.0040212

Ejemplares similares

The role of neuraminidase inhibitors in the treatment and prevention of influenza
por: Naem, Shahrour
Publicado: (2001)

Heterotypic Neuraminidase Antibodies Against Different A(H1N1) Strains are Elicited after Seasonal Influenza Vaccination
por: Mendez-Legaza, Jose Manuel, et al.
Publicado: (2019)

Diagnóstico microbiológico de las infecciones virales respiratorias
por: Eiros, José M., et al.
Publicado: (2009)

Immunopathogenesis of 2009 pandemic influenza
por: Almansa, Raquel, et al.
Publicado: (2012)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Influenza C Virus Infection in Children, Spain
por: Calvo, Cristina, et al.
Publicado: (2006)

Global influenza surveillance in times of COVID-19: Robbing Peter to pay Paul?()
por: Sanz-Muñoz, I., et al.
Publicado: (2021)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India
por: Ranganath, Prajnya, et al.
Publicado: (2012)

Influenza Virus Neuraminidase: Structure and Function
por: Shtyrya, Y.A., et al.
Publicado: (2009)

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
por: Gamblin, Steven J., et al.
Publicado: (2010)

Influenza Virus Neuraminidase Structure and Functions
por: McAuley, Julie L., et al.
Publicado: (2019)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

Mechanism of 150-cavity formation in influenza neuraminidase
por: Amaro, Rommie E., et al.
Publicado: (2011)

Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011)

Exploring the chemical space of influenza neuraminidase inhibitors
por: Anuwongcharoen, Nuttapat, et al.
Publicado: (2016)

Aurintricarboxylic acid inhibits influenza virus neuraminidase
por: Hung, Hui-Chen, et al.
Publicado: (2009)

Inherent Serum Inhibition of Influenza Virus Neuraminidases
por: Skarlupka, Amanda L., et al.
Publicado: (2021)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Ecological fallacy in COVID-19 epidemiological inference: Influenza vaccination rate as an example
por: Chen, Yi-Chu, et al.
Publicado: (2021)

Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010‐2016
por: Oliva, Jesús, et al.
Publicado: (2017)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Variable ligand- and receptor-binding hot spots in key strains of influenza neuraminidase
por: Votapka, Lane, et al.
Publicado: (2012)

Geographical and socioeconomic disparities in the use of percutaneous coronary intervention in the Philippines
por: Callanta, Maria Llaine J., et al.
Publicado: (2022)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
por: Lee, Vernon J., et al.
Publicado: (2006)

Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza
por: Ward, Melissa J, et al.
Publicado: (2013)

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
por: Kamali, Amanda, et al.
Publicado: (2013)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
por: Creytens, Sarah, et al.
Publicado: (2021)

Cobrotoxin could be an effective therapeutic for COVID-19
por: Lin, Fang, et al.
Publicado: (2020)

Could A Deletion in Neuraminidase Stalk Strengthen Human Tropism of the Novel Avian Influenza Virus H7N9 in China, 2013?
por: Chen, Liang, et al.
Publicado: (2015)

Aplicación de los métodos moleculares al diagnóstico y el estudio epidemiológico de las infecciones respiratorias causadas por virus
por: Pozo, Francisco, et al.
Publicado: (2008)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Could SARS-CoV-2 cause tauopathy?
por: Pratt, James, et al.
Publicado: (2021)

Divergent vaccination policies could fuel mistrust and hesitancy
por: Forman, Rebecca, et al.
Publicado: (2021)

Cost–effectiveness analysis of quadrivalent influenza vaccine in Spain
por: García, Amos, et al.
Publicado: (2016)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010–2015
por: Tewawong, Nipaporn, et al.
Publicado: (2018)

Identification of critical residues of influenza neuraminidase in viral particle release
por: Tisoncik, Jennifer R, et al.
Publicado: (2011)

Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
por: Mizuno, Takuro, et al.
Publicado: (2014)

Biophysical Measurement of the Balance of Influenza A Hemagglutinin and Neuraminidase Activities
por: Benton, Donald J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r8ki9suur2e5uru90t419vthea